Skip to main content
. 2020 Nov 24;9:e61981. doi: 10.7554/eLife.61981

Figure 2. What the future holds?

Percentage of genes with indicated levels of support by the four genome-wide studies which have been tagged at least once in the COVID-19 literature. (A) Analysis restricted to the 50% of genes with highest number of publications in non-COVID-19 literature. (B) Analysis restricted to the 50% of genes with the lowest number of publications in the non-COVID-19 literature. (C) Cumulative share of literature on human protein-coding genes tagged in the COVID-19 literature. Top 20% indicates the 20% of genes that occur the most in the non-COVID-19 literature. Gene rank refers to the order of human protein-coding genes. The gene with the most publication equivalents would be have rank 1. Yellow area indicates share of literature accounted for by the top 20% genes. (D) Share of COVID-19 literature accounted for by the 20% of genes that had occurred the most in the COVID-19 literature by a given date. (E) Number of distinct human protein coding genes that have been tagged in the literature by a given date. (F) Share of COVID-19 literature accounted for by first 100 genes to be tagged in the COVID-19 literature by a given date.

Figure 2.

Figure 2—figure supplement 1. Temporal trends in the diversity of COVID-19 research.

Figure 2—figure supplement 1.

(A) Gini Coefficient within COVID-19 literature until indicated day (green dots). (B) As Figure 2D but considering individual months (ochre dots). (C) As Figure 2F but considering individual months (purple dots). Note that September is the last month shown as October had been indexed incompletely within the most recent release of the database providing publication dates of for the COVID-19 literature.